Card image cap

Ed Markey's Public Statements on Issue: Drugs

Office:
Page 1 of 12

Date Title
09/27/2023 Durbin, Markey Press Administration To Track $50 Billion In Opioid Settlement Money From Drug Corporations, Ensure Used For Public Health & To Address Opioid Epidemic
10/21/2022 Letter to Alejandro Mayorkas, Secretary of Homeland Security, Louis DeJoy, Postmaster General of the United States - Markey, Trone Urge Biden Admin to Ramp Up Efforts to Stop Synthetic Opioid Trafficking Through the Mail
09/28/2022 Letter to Lloyd Austin, Secretary of Defense - Senator Markey Raises Alarm on Fatal Overdoses Among Active Duty Service Members
07/25/2022 Letter to Hon. Robert M. Califf, Commissioner of the FDA - Senator Baldwin Voices Support for FDA's Proposed "Life-Saving" Ban on Menthol Cigarettes and Flavored Cigars
06/28/2022 SENATOR MARKEY JOINS SENATOR BOOKER, COLLEAGUES IN RAISING CONCERNS OVER PERMANENT CLASSWIDE SCHEDULING OF FENTANYL ANALOGUES
05/23/2022 MARKEY, TRONE URGE PRESIDENT BIDEN TO ACT ON OPIOID CRISIS BY ENACTING RECOMMENDATIONS FROM OPIOID COMMISSION REPORT
05/20/2022 Letter to Robert M. Califf, MD, Commissioner of the US Food and Drug Administration - Senator Baldwin, Democratic Colleagues To FDA Commissioner: Remove All Unauthorized E-Cigarettes From Market Immediately
04/21/2022 Senator Markey Applauds Biden Administration's Drug Control Strategy for Focus on Treatment, Harm Reduction, and Fentanyl Trafficking
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
02/16/2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC
02/15/2022 SENATOR MARKEY VOTES AGAINST DR. ROBERT CALIFF NOMINATION FOR FDA COMMISSIONER
02/10/2022 Dr. Paul, Sen. Markey Introduce Bipartisan Legislation to Modernize, Improve Methadone Treatment Amid Skyrocketing Opioid Overdoses and Deaths
02/10/2022 SENATORS MARKEY AND PAUL INTRODUCE BIPARTISAN LEGISLATION TO MODERNIZE, IMPROVE METHADONE TREATMENT AMID SKYROCKETING OPIOID OVERDOSES AND DEATHS
02/08/2022 MARKEY JOINS TRONE, COTTON IN LEADING U.S. COMMISSION ON COMBATING SYNTHETIC OPIOID TRAFFICKING, RELEASE FINAL REPORT OUTLINING ITS KEY FINDINGS AND PROPOSALS
01/13/2022 Letter to Hon. Janet Woodcock MD, Acting Commissioner FDA - SENATOR MARKEY OUTLINES OPPOSITION TO FDA COMMISSIONER NOMINEE DR. ROBERT CALIFF, CALLS FOR REFORMS AT FDA TO ADDRESS FAILURES THAT LEAD TO, WORSENED OPIOID EPIDEMIC
12/21/2021 Van Hollen, Warren, Baldwin, Maloney Reintroduce Landmark CARE Act to Combat the Substance Use Epidemic
12/16/2021 Baldwin, Warren, Maloney Lead More than 100 Democrats in Senate and House in Reintroducing Landmark CARE Act to Combat the Substance Use Epidemic
12/07/2021 Senator Markey and Rep. Cicilline Reintroduce Legislation to Address Over-Manufacture of Opioid Painkillers, Spur Transparency in Approval Process at DEA
11/18/2021 Senator Markey Applauds Biden Admin Extension of Methadone Take-Home Flexibilities After His Urging
11/10/2021 Letter to Hon. Joseph R. Biden, President of the United States - Markey, Warren, and Merkley Urge Biden to Issue Blanket Cannabis Pardons
10/14/2021 Senators Markey, Murkowski and Representative Kuster Reintroduce Bipartisan, Bicameral Legislation to Expand Access to Opioid Treatment in Correctional Facilities
09/02/2021 Markey Slams Purdue Pharma Opioid Bankruptcy Settlement, Calls on Department of Justice to Appeal Ruling
08/31/2021 Senator Markey Leads Senate Resolution to Recognize August 31 as "Overdose Awareness Day"
08/23/2021 Letter to Janet Woodcock, Acting Commissioner of Food and Drug Administration - Senators Hassan, Grassley, and Whitehouse Lead Call to FDA to Provide Answers on Potential Conflicts of Interest with Consulting Firm McKinsey in Relation to Opioid Crisis

Page 1 of 12
arrow_upward